← Back to Clinical Trials
Recruiting NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Rectal Cancer
Sponsor University Hospital Tuebingen
Study Type INTERVENTIONAL
Phase N/A
Enrollment 472
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2018-05-09
Completion 2022-05-09
All Conditions
Interventions
Radiotherapy on the MR-LinacImaging on the MR Linac
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.
Eligibility Criteria
Inclusion Criteria: * existing indication for radiation therapy * minimum age 18 years, no upper age limit * capacity for consent * Informed consent Exclusion Criteria: * contraindication for MRI (claustrophobia, metallic implants not applicable for MRI * pregnancy
Related Trials
NCT06210971
Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Re
View Trial →
NCT06923345
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk
View Trial →
NCT06923150
A Randomised Clinical Investigation to Assess Efficacy of Low Volume Transanal Irrigation by Qufora®
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology